Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Outcome By Mutation Status and Line of Treatment in Optic, a Dose-Ranging Study of 3 Starting Doses of Ponatinib in Patients with CP-CML

Jorge E. Cortes, MD, Jane Apperley, FRCP, FRCPath, MB, Andreas Hochhaus, MD, Michael J. Mauro, MD, Philippe Rousselot, MDPhD, Tomasz Sacha, MDPhD, Moshe Talpaz, MD, Charles Chuah, MD, Jeffrey H. Lipton, MD PhD, Michael W. Deininger, MD PhD, Charles A. Schiffer, MD, Lori J. Maness, MD, James K. McCloskey, MD, Valentín García Gutiérrez, MD PhD, Hugues de Lavallade, MD PhD, Gabriel Etienne, MD PhD, Vickie Lu, PhD, Shouryadeep Srivastava, MBBS, PhD, Gianantonio Rosti, MD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-135883

Published: 2020

Journal Articles

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Valerie K Shostrom, Sarah A. Holstein, MD PhD, Zaid S. Al-Kadhimi, MD, Lori J. Maness, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Krishna Gundabolu, MBBS

Blood (2019) 134 (Supplement_1): 2155.

https://doi.org/10.1182/blood-2019-122679

Published: 2019

Journal Articles

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Christopher Wichman, PhD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Sarah A. Holstein, MD PhD, Krishna Gundabolu, MBBS, Lori J. Maness, MD

Blood (2019) 134 (Supplement_1): 120.

https://doi.org/10.1182/blood-2019-124375

Published: 2019

Journal Articles

Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)

Prajwal Dhakal, MBBS, Elizabeth R. Lyden, MS, Kate-Lynn E Muir, MD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2019) 134 (Supplement_1): 5086.

https://doi.org/10.1182/blood-2019-124000

Published: 2019

Journal Articles

Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles

Blood (2017) 130 (Supplement 1): 891.

https://doi.org/10.1182/blood.V130.Suppl_1.891.891

Published: 2017

Journal Articles

Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)

Andrea J. Lee, BS, Elizabeth R. Lyden, MS, Lakshmi Manogna Chintalacheruvu, MD, Thuy Thi Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2017) 130 (Supplement 1): 5659.

https://doi.org/10.1182/blood.V130.Suppl_1.5659.5659

Published: 2017

Journal Articles

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Lori J. Maness, MD, Jiangtao Luo, Avyakta Kallam, MBBS, James O. Armitage, MD, Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Matthew Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 5154.

https://doi.org/10.1182/blood.V128.22.5154.5154

Published: 2016

Journal Articles

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Smith Giri, MBBS, Valerie Shostrom, MS, Krishna Gundabolu, MD, KM Monirul Islam, MDPhD, Ranjan Pathak, MD, Lori J. Maness, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 533.

https://doi.org/10.1182/blood.V126.23.533.533

Published: 2015

Journal Articles

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Roberto A. Ferro, MD, Valerie Shostrom, MS, Julie M. Vose, MD, Krishna Gundabolu, MD, Smith Giri, MBBS, KM Monirul Islam, MDPhD, Lori J. Maness, MD, James Olen Armitage, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 268.

https://doi.org/10.1182/blood.V126.23.268.268

Published: 2015

Journal Articles

Concurrent Somatic Mutations in Exon 14 of Janus KINASE2 (JAK2) and Exon 10 of Myeloprolifeative Leukemia Virus Oncogene (MPL) in Myeloproliferative Neoplasms (MPN) and Myelodysplastic Syndromes (MDS)/MPN

Krishna Gundabolu, MD, Catalina C Amador, MD, Allison M Cushman-Vokoun, MD, PhD, Vijaya R. Bhatt, MD, Lori J. Maness, MD, Timothy C. Greiner, MD

Blood (2015) 126 (23): 5211.

https://doi.org/10.1182/blood.V126.23.5211.5211

Published: 2015

Journal Articles

Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism

Krishna Gundabolu, MD, Vijaya R. Bhatt, MD, Lori J. Maness, MD, Catalina C Amador, MD, Marco Olivera, MD, Fedja A Rochling, MD

Blood (2015) 126 (23): 4719.

https://doi.org/10.1182/blood.V126.23.4719.4719

Published: 2015

Journal Articles

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Nabin Khanal, MBBS, R. Gregory Bociek, MD, Baojiang Chen, PhD, Julie M. Vose, MD, James O. Armitage, MD, Philip J Bierman, MD, Lori J. Maness, MD, Matthew A. Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 3482.

https://doi.org/10.1182/blood.V126.23.3482.3482

Published: 2015

Journal Articles

Restrospective Review of Incidence, Complications and Management of Tumor Lysis Syndrome in High Risk Patients with Hematologic Malignancies

Devon M Greer, PharmD, Jairam Krishnamurthy, MD, Susanne Liewer, PharmD, Mojtaba Akhtari, MD, Lori J. Maness, MD, R. Gregory Bociek, MD

Blood (2014) 124 (21): 2621.

https://doi.org/10.1182/blood.V124.21.2621.2621

Published: 2014

Journal Articles

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Older Patients with Myelodysplastic Syndrome (MDS) Refractory to Hypomethylating Agents.

Guillermo Garcia-Manero, MD, Selina Luger, MD, Parameswaran Venugopal, MD, Lori J. Maness, MD, Meir Wetzler, MD, Jessica Altman, MD, David F. Claxton, M.D., Stephen Strickland, MD, Stefan Faderl, MD, Judy Chiao, MD, Hagop M. Kantarjian, MD

Blood (2009) 114 (22): 1758.

https://doi.org/10.1182/blood.V114.22.1758.1758

Published: 2009

Journal Articles

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Elderly Patients with AML Previously Untreated or in First Relapse.

Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Selina Luger, MD, Parameswaran Venugopal, MD, Lori J. Maness, MD, Meir Wetzler, MD, Wendy Stock, MD, Steven Coutre, MD, Gautam Borthakur, MD, Judy Chiao, MD

Blood (2009) 114 (22): 1061.

https://doi.org/10.1182/blood.V114.22.1061.1061

Published: 2009

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

John D. Dickinson, MD, PhD, Fausto Loberiza, MD, Victoria Whalen, Philip J. Bierman, MD, Julie M. Vose, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, James O. Armitage, MD, Greg Bociek, MD

Blood (2007) 110 (11): 3045.

https://doi.org/10.1182/blood.V110.11.3045.3045

Published: 2007

Journal Articles

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Apar Kishor Ganti, MD, Stephanie J. Lee, MD, MPH, James O. Armitage, MD, Philip J. Bierman, MD, Gregory Bociek, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Elizabeth C. Reed, MD, Julie M. Vose, MD, Fausto Loberiza, MD, MS

Blood (2005) 106 (11): 2025.

https://doi.org/10.1182/blood.V106.11.2025.2025

Published: 2005

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD

Blood (2005) 106 (11): 3671.

https://doi.org/10.1182/blood.V106.11.3671.3671

Published: 2005

Journal Articles

Can Elimination of Total Body Irradiation (TBI) in Conditioning Regimens for Autologous Stem Cell Transplantation (SCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma Decrease the Risk of Secondary AML/MDS(sAML/MDS)? A Retrospective Case-Control Study at the University of Nebraska Medical Center.

Lori J. Maness, MD, F. R. Loberiza, MD, W. Sanger, PhD, M. P. DeVetten, MD, P. Bierman, MD, G. Bociek, MD, J. O. Armitage, MD, J. M. Vose, MD

Blood (2005) 106 (11): 682.

https://doi.org/10.1182/blood.V106.11.682.682

Published: 2005

NARROW

Outcome By Mutation Status and Line of Treatment in Optic, a Dose-Ranging Study of 3 Starting Doses of Ponatinib in Patients with CP-CML

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)

Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles

Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Concurrent Somatic Mutations in Exon 14 of Janus KINASE2 (JAK2) and Exon 10 of Myeloprolifeative Leukemia Virus Oncogene (MPL) in Myeloproliferative Neoplasms (MPN) and Myelodysplastic Syndromes (MDS)/MPN

Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Restrospective Review of Incidence, Complications and Management of Tumor Lysis Syndrome in High Risk Patients with Hematologic Malignancies

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Older Patients with Myelodysplastic Syndrome (MDS) Refractory to Hypomethylating Agents.

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Elderly Patients with AML Previously Untreated or in First Relapse.

Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

Can Elimination of Total Body Irradiation (TBI) in Conditioning Regimens for Autologous Stem Cell Transplantation (SCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma Decrease the Risk of Secondary AML/MDS(sAML/MDS)? A Retrospective Case-Control Study at the University of Nebraska Medical Center.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only